TAGCYX BIOTECHNOLOGIES INC.
www.tagcyx.comTAGCyx’s scientific team has established its proprietary Xenoligo® technology platform, allowing high functional oligonucletide drug discovery. The Xenoligo® platform utilizes genetic alphabet expansion by unnatural base-pairs to generate customized nucleic acid suited for therapeutic applications.
Read moreTAGCyx’s scientific team has established its proprietary Xenoligo® technology platform, allowing high functional oligonucletide drug discovery. The Xenoligo® platform utilizes genetic alphabet expansion by unnatural base-pairs to generate customized nucleic acid suited for therapeutic applications.
Read moreCountry
City (Headquarters)
Tokyo
Industry
Employees
11-50
Founded
2007
Social
Employees statistics
View all employeesPotential Decision Makers
President and Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Consultant
Email ****** @****.comPhone (***) ****-****
Reach decision makers at TAGCYX BIOTECHNOLOGIES INC.
Free credits every month!
TAGCYX BIOTECHNOLOGIES INC. FAQ
Biotechnology Research